CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for FAES Farma SA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

FAES Farma SA
Edificio 2, 2 Izquierda
Phone: +34 914680800p:+34 914680800 MADRID, MAD  28033  Spain Ticker: FAEFAE
Business Summary
Faes Farma SA is a Spain-based company engaged in the pharmaceutical industry. The Company specializes in the research, production, distribution and sale of prescription and generic drugs, over-the-counter (OTC) medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The Company’s research lines are mainly focused on the development of new drugs for the treatment of allergy, venous insufficiency and irritable bowel syndrome, among others. In addition, it provides animal nutrition products. The Company operates in Spain, Portugal, Chile and Mexico, among others. It controls a number of subsidiaries, such as Laboratorios Vitoria SA, Laboratorios Veris SA, Lazlo International SA, Ingaso Farm SLU, Esfion SA and Biotecnet I MAS D SA.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2836 Biological products, except diagnostic substances
2819 Industrial inorganic chemicals, not elsewhere classified
2869 Industrial organic chemicals, not elsewhere classified
8731 Commercial physical and biological research
2048 Prepared feeds and feed ingredients for animals and fowls, except dog and cat
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board MarianoUcar Angulo 6/25/2013 5/16/1991
Deputy General Director, Corporate Chief Financial Officer ValentinRuiz Unamunzaga
General Director GonzaloLopez Casanueva
8 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
BCN Medical SA Cra. 65b ## 10-77 Bogota Colombia

Business Names
Business Name
0K9H
BCN Medical SA
FAE
5 additional Business Names available in full report.

General Information
Number of Employees: 1,748 (As of 12/31/2023)
Outstanding Shares: 311,248,691 (As of 12/31/2023)
Shareholders: 573,431
Stock Exchange: MCE
Fax Number: +34 944818201


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, April 22, 2024